HomeQuestion

What is your preferred duration of aggrastat therapy, and does it differ if patient presented with NSTEMI versus STEMI?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?

What are your preferred guide catheters to use for engaging coronaries in patients with mechanical or bioprosthetic aortic valves?

Would acute-onset thrombocytopenia and concern for active bleeding with platelet count below 50,000 prompt you to hold plavix and/or aspirin following PCI that was done 1-2 weeks ago?

Are there specific types/brands of drug-eluting stent you prefer that perform well in terms of lower ISR rates or ones that are better for patients with high bleeding risk?

What is a reasonable minimal duration of DAPT following drug coated balloon angioplasty for ISR lesions?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.